docetaxel anhydrous has been researched along with azd2014 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (azd2014) | Trials (azd2014) | Recent Studies (post-2010) (azd2014) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 76 | 8 | 72 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | azd2014 (IC50) |
|---|---|---|---|
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | 3.8 | |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 3.8 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0521 | |
| Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.2 | |
| Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Y; Hu, S; Jin, J; Li, S; Liu, Z; Lv, T; Sheng, J; Song, Y; Yu, W; Zhang, C | 1 |
1 other study(ies) available for docetaxel anhydrous and azd2014
| Article | Year |
|---|---|
Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel-sensitive and docetaxel-resistant castration-resistant prostate cancer cells.
Topics: Apoptosis; Autophagy; Benzamides; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Immunophenotyping; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Morpholines; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction | 2021 |